Calypso Biotech Company
Calypso Biotech is an innovative biopharmaceutical company based in Geneva, Switzerland and founded in 2013 as a spin-off from Merck Serono, a global leader in auto-immune diseases and biologics. Calypso Biotech was initially financed through a 2.5 million euro seed-fund managed by MS Ventures.A highly experienced management team with strong expertise in drug development and an extensive scientific and industry network manages Calypso Biotech. They operate as a nimble, semi-virtual organization in order to create substantial added value for their investors from a portfolio of unique proprietary antibody candidates.
Investors
Headquarters:
Plan-les-ouates, Geneve, Switzerland, Europe
Founded Date:
2013-01-01
Industry:
Drug Discovery & Development
Employee Number:
11-50
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41225523307
Investors:
Fountain Healthcare Partners, Gilde Healthcare, Inkef, Johnson & Johnson Innovation, M Ventures
Ipo Status:
private
City:
Plan-les-Ouates
Region:
Geneve
Country:
Switzerland
Founders:
Alain Vicari, Yolande Chvatchko